CD5 and neoplasm: In that respect, in a mouse model of pancreatic ductal adenocarcinoma, treatment with BTK inhibitor induces a reduction in tumor growth which was associated with a depletion or decreased presence of IgMloCD23+CD5− follicular and IgMlo CD23− memory B cells [119].